講演・口頭発表等 - 稲澤　譲治

分割表示  781 件中 61 - 80 件目  ／  全件表示 >>

  1. 平本 秀一, 村松 智輝, 市川 大輔, 大辻 英吾, 稲澤 譲治. miR-509-5pとmiR-1243は膵癌においてEMTを抑制する. 日本癌学会総会記事 2017.09.01

  2. Inazawa J. Exploring novel cancer-related microRNAs and their diagnostic and therapeutic potentials in Precision Cancer Medicine.. International Conference for Precision Cancer Medicine 2017 2017.06.29 Tokyo, Japan

  3. Inoue J, Takahashi H, Sakaguchi K, Takagi M, Mizutani S, Inazawa J. Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells. 108th annual meeting of American Association for Cancer Research 2017 2017.04.04 Washington D.C., USA

  4. Akdemir B, Inoue J, Kawano T, Inazawa J. High expression of MiR-432-3p is associated with the chemoresistance by NRF2 stabilization via directly targeting KEAP1. 108th annual meeting of American Association for Cancer Research 2017 2017.04.03 Washington D.C., USA

  5. Furusawa A, Inoue J, Tsuda H, Miyasaka N, Inazawa J. Differential requirement of amino acids on cell survival of ovarian cancer cells. 108th annual meeting of American Association for Cancer Research 2017 2017.04.03 Washington D.C., USA

  6. Inazawa J. Autophagy, p62-NRF2-Keap1-ARE Pathway and Micro RNAs in Overian Cancer. The 4th Annual Meeting of the International Ovarian Cancer Consortium on Tumor Microenviroment and Drug Discovery. 2017.02.23 Seoul, Korea

  7. Furusawa Akiko, Inoue Jun, Miyasaka Naoyuki, Inazawa Johji. 卵巣細胞癌の細胞生存におよぼすアミノ酸の差異的要件(Differential requirement of amino acids on cell survival of ovarian cancer cells). 日本産科婦人科学会雑誌 2017.02.01

  8. Oikawa Yu, Morita Kei-ichi, Kayamori Kou, Tanimoto Kousuke, Sakamoto Kei, Katoh Hiroto, Ishikawa Shumpei, Inazawa Johji, Harada Hiroyuki. 口腔扁平上皮癌患者では受容体チロシンキナーゼの増幅により遠隔転移が予測される(Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma). Cancer Science 2017.02.01

  9. Inazawa J. Autophagy,Nutrition and Cancer.. Wellness Symposium with NAPA2016 2016.11.03 Seoul, Korea

  10. Inazawa J. Identification of Novel Tumor-suppressor Micro-RNAs and Their Application for Cancer Diagnosis and Therapeutics.. Third Annual Meeting of the International Ovarian Cancer Consortium in conjunction with International Symposium on Tumor Microenvironment and Therapy Resistance. 2016.08.28 Oklahoma City,USA

  11. Inazawa J. Cancer Omics for Precision Medicine. 19th Annual Meeting of the Korean Urogynecologic Society 2016.07.02 Seoul, Korea

  12. Muramatsu T, Tanimoto K, Inazawa J. Exploring target genes of eukaryotic initiation factor 5A in cancer using RNA sequence analysis. 107th annual meeting of American Association for Cancer Research 2016 2016.04.18 New Orleans, USA

  13. Inoue J, Fujiwara N, Yamamoto S, Kawano T, Inazawa J. MicroRNA-based diagnosis and therapy in NRF2-stabilized tumor. 107th annual meeting of American Association for Cancer Research 2016 2016.04.18 New Orleans, USA

  14. Uehara D.T, S Hayashi, Makita Y ,Hata A, Imoto I ,Inazawa J. Screening of copy number variants in 450 Japanese subjects presenting with intellectual disability (ID) and multiple congenital anomalies (MCA) by SNP array unveiling rare small variants and PPFIA2 as a novel candidate gene for ID. ICHG2016 2016.04.05 Kyoto, Japan

  15. Morita K,Naruto T, Tanimoto K, Yasukawa C, Oikawa Y, Masuda K, Imoto I, Inazawa J. Simultaneous detection of both single nucleotide variations and copy number alterations by nextgeneration sequencing in Gorlin syndrome.. ICHG2016 2016.04.01 Kyoto, Japan

  16. Kanai M, Okada Y, Muramatsu T, Suita N, Kawakami E, Iotchkova V, Soranzo N, Inazawa J, Tanaka T. Significant impact of miRNA-target gene networks on genetics of human complex traits. ICHG2016 2016.04.01 Kyoto, Japan

  17. Inazawa　J. High expression of SQSTM1/p62 protein is associated with poor prognosis in epithelial ovarian cancer. Second Annual Meeting of the International Ovarian Cancer Consortium in conjunction with International Symposium on Tumor Microenvironment and Therapy Resistance 2015.08.17 Oklahoma City,USA

  18. Michelle N,Inoue J,Kawano T,Inazawa J. Inactivation of LAPTM5 gene in human cancer. The 34th Sapporo International Cancer Symposium. . The 34th Sapporo International Cancer Symposium 2015.06.26 Sapporo, Japan

  19. Inoue J,Inazawa J. Screening of autophagy modulators for cancer therapy using high-content imaging system. The 34th Sapporo International Cancer Symposium 2015.06.26 Sapporo, Japan

  20. Muramatsu T,Kozaki K,Imoto S,Yamaguchi R,Tsuda H,Kawano T,Fujiwara N,Morishita M,Miyano S,Inazawa J. The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma . The 34th Sapporo International Cancer Symposium 2015.06.26 Sapporo, Japan

< 前のページ - 次のページ >

このページの先頭へ▲